Diana R. Fonseca

Diana R. Fonseca

Auto-generated profile, based on publicly available information

Diana R. Fonseca

I3S-Instituto de Investigação e Inovação em Saúde, Rua Alfredo Allen, 208, Porto 4200-135, Portugal; INEB-Instituto de Engenharia Biomédica, Rua Alfredo Allen, 208, Porto 4200-135, Portugal

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
RSRita Sobreiro-Almeida
Rita Sobreiro-Almeida
DFDiana R. Fonseca
Diana R. Fonseca
Nuno M. NevesNuno M. Neves
Nuno M. Neves

6 April 2024 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
LSLarissa Spósito
Larissa Spósito
DFDiana Fonseca
Diana Fonseca
SCSuzana Gonçalves Carvalho
Suzana Gonçalves Carvalho
RSRafael Miguel Sábio
Rafael Miguel Sábio
Gabriel Davi MarenaGabriel Davi Marena
Gabriel Davi Marena
Marlus ChorilliMarlus Chorilli
Marlus Chorilli

30 April 2018 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
DFDiana R. Fonseca
Diana R. Fonseca
RSRita Sobreiro-Almeida
Rita Sobreiro-Almeida
PSPaula C. Sol
Paula C. Sol
Nuno M. NevesNuno M. Neves
Nuno M. Neves
Non-orthogonal scaffolds positively influenced the osteogenic performance of a Saos-2 cell line, presenting a larger amount of calcium phosphate deposition.

14 March 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
DFDiana R Fonseca
Diana R Fonseca
Pedro M AlvesPedro M Alves
Pedro M Alves
ENEstrela Neto
Estrela Neto
BCBeatriz Custódio
Beatriz Custódio
SGSofia Guimarães
Sofia Guimarães
MMMaria Cristina Martins
Maria Cristina Martins
Surface bioconjugation of antimicrobial peptides (AMP) onto nanoparticles (AMP-NP) is a complex, multistep, and time-consuming task. Herein, a microfluidic system for the one-pot production of AMP-NP was developed. Norbornene-modified chitosan was used for NP production (NorChit-NP), and thiolated-AMP was grafted on their surface via thiol-norbornene "photoclick" chemistry over exposure of two parallel UV LEDs. The MSI-78A was the AMP selected due to its high activity against a high priority (level 2) antibiotic-resistant gastric pathogen: Helicobacter pylori (H. pylori). AMP-NP (113 ± 43 nm; zeta potential 14.3 ± 7 mV) were stable in gastric settings without a cross-linker (up to 5 days in pH 1.2) and bactericidal against two highly pathogenic H. pylori strains (1011 NP/mL with 96 μg/mL MSI-78A). Eradication was faster for H. pylori 26695 (30 min) than for H. pylori J99 (24 h), which was explained by the lower minimum bactericidal concentration of soluble MSI-78A for H. pylori 26695 (32 μg/mL) than for H. pylori J99 (128 μg/mL). AMP-NP was bactericidal by inducing H. pylori cell membrane alterations, intracellular reorganization, generation of extracellular vesicles, and leakage of cytoplasmic contents (transmission electron microscopy). Moreover, NP were not cytotoxic against two gastric cell lines (AGS and MKN74, ATCC) at bactericidal concentrations. Overall, the designed microfluidic setup is a greener, simpler, and faster approach than the conventional methods to obtain AMP-NP. This technology can be further explored for the bioconjugation of other thiolated-compounds.

15 February 2024 in Applied Materials Today
Verified
Journal Article
Open access
DFDiana R. Fonseca
Diana R. Fonseca
RCRute Chitas
Rute Chitas
Paula ParreiraPaula Parreira
Paula Parreira
MMMaria Cristina Martins
Maria Cristina Martins